-
Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens
来源: Buzz FX / 02 1月 2025 08:51:14 America/Chicago
Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Blueprint Medicines ( NASDAQ:BPMC - Get Free Report ) 's stock had its "overweight" rating restated b
Read more...